Australia TGA CDSS Exemption Changes: New 2026 Rules for SaMD

Australia's Therapeutic Goods Administration (TGA) has significantly narrowed the exemption criteria for Clinical Decision Support Software (CDSS), with new rules taking effect on November 1, 2026. This episode details the two key changes: exempt CDSS must not be intended to make a diagnosis on its own, and it must transparently display the logic and sources behind its recommendations for a healthcare professional to verify. We discuss how this impacts Software as a Medical Device (SaMD) manufacturers whose products may no longer qualify for exemption and will now require full TGA registration. Learn the practical steps your team must take now to assess your product, perform a gap analysis, and prepare a regulatory strategy to ensure continued market access in Australia. Key Questions: - What are the specific changes to Australia's CDSS exemption rules for 2026? - When do the new TGA requirements for SaMD take effect? - How does the TGA now define a CDSS that is exempt from regulation? - What does it mean for software to 'display its logic' for a healthcare professional? - Will my previously exempt diagnostic software now require TGA registration? - What are the first steps to take if my CDSS no longer qualifies for exemption? - How should I re-evaluate my product's claims and intended purpose? - What is the impact of these changes on AI-enabled medical software startups in Australia? Sources: - https://www.viridianlawyers.com.au/blog/saas-lawyer-australia/software-as-a-medical-device-how-the-tga-regulates-digital-health-and-ai-enabled-medical-software-startups-in-australia - https://www.medtech.org.au/september-28th-october-2nd-2026/ How Pure Global can help: Pure Global provides end-to-end regulatory consulting to help MedTech and IVD companies navigate complex global markets like Australia. Our experts can assist with re-evaluating your CDSS against the new TGA criteria, developing a comprehensive regulatory strategy if registration is now required, and acting as your official Australian Sponsor. We use advanced AI tools to efficiently compile, manage, and submit the technical dossier needed for TGA approval, streamlining your path to compliance. Whether you are a startup or a multinational, we ensure you can maintain and expand your market presence efficiently. Contact us at info@pureglobal.com, visit https://pureglobal.com, or explore our free AI tools and regulatory database at https://pureglobal.ai.